Adkins Biosciences participates to the Matching Day # 2 organized by the Cancéropôle PACA
Emilie Robert, CEO of Adkins Biosciences, introduced the strengths of the new subsidiary during Matching Day#2 focusing on 3D models for academic and clinical research in oncology.
Adkins Biosciences is therefore supporting from the start of an initiative aimed at setting up a national organoid biobanking subsidiary in order to provide academic and private researchers with study models that meet ethical, regulatory and technological best practices.
Learn more about Matching Day#2